Jin Medical International (ZJYL) Change in Accured Expenses (2022 - 2025)

Jin Medical International has disclosed Change in Accured Expenses across 4 years of filings, most recently posting $450453.0 for Q1 2025.

• Change in Accured Expenses for Q1 2025 came in at $450453.0, down 14.66% year-over-year; the trailing twelve-month figure through Mar 2025 was $450453.0 (down 14.66% YoY), and the FY2025 annual result was $245925.0, down 42.94% from the prior year.
• Change in Accured Expenses came in at $450453.0 for Q1 2025 at Jin Medical International, up from $431003.0 in the prior quarter.
• In the past five years, Change in Accured Expenses ranged from a high of $527822.0 in Q1 2024 to a low of $318500.0 in Q3 2023.
• The 4-year median for Change in Accured Expenses is $412381.5 (2022), against an average of $416605.8.
• Across the five-year window, Change in Accured Expenses fell 19.11% in 2023 and soared 39.6% in 2024, its largest moves.
• Jin Medical International's Change in Accured Expenses stood at $393760.0 in 2022, then slipped by 19.11% to $318500.0 in 2023, then jumped by 35.32% to $431003.0 in 2024, then climbed by 4.51% to $450453.0 in 2025.
• The last three Change in Accured Expenses figures came in at $450453.0 (Q1 2025), $431003.0 (Q3 2024), and $527822.0 (Q1 2024), per Business Quant data.